Cargando…

A Retrospective Analysis of Denosumab for the Treatment of Bone Metastases in Chinese Patients With Breast Cancer

BACKGROUND: Denosumab entered the Chinese market for the first time in 2020. Since it is a short period of time, there is a lack of data on its effectiveness and safety in Chinese people. The objective of this study was to evaluate the effectiveness and safety of denosumab in delaying skeletal-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Wu, Xinyu, Yu, Heng, Zhu, Zekai, Li, Wenjie, Huang, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336762/
https://www.ncbi.nlm.nih.gov/pubmed/37448470
http://dx.doi.org/10.1177/11795549231182266

Ejemplares similares